This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Corporation. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Innovations of James Joseph Hagan
Introduction
James Joseph Hagan is a notable inventor based in Herts, GB. He has made significant contributions to the field of medical science, particularly in the treatment of diseases related to neuropeptide receptors. His innovative work has led to the development of novel methods that can potentially improve patient outcomes.
Latest Patents
Hagan holds a patent for "Methods for treatment using novel ligands of the neuropeptide receptor HFGAN72." This patent includes polypeptides of HFGAN72 receptor ligands and polynucleotides encoding these polypeptides. The methods described in the patent aim to diagnose or treat diseases associated with the under- or over-expression of HFGAN72 receptor ligands. Additionally, the patent outlines methods for identifying agonists or antagonists that interact with the HFGAN72 receptor. These methods also include treatment protocols for administering the identified compounds to patients in need.
Career Highlights
Hagan is associated with SmithKline Beecham Corporation, where he has been able to apply his expertise in neuropeptide research. His work has been instrumental in advancing the understanding of neuropeptide receptors and their implications in various medical conditions.
Collaborations
Hagan has collaborated with notable colleagues such as Saraswati R Patel and Neil Upton. These collaborations have further enriched his research and contributed to the development of innovative treatment methods.
Conclusion
James Joseph Hagan's contributions to the field of medical science through his patent and collaborative efforts highlight his role as a significant inventor. His work continues to pave the way for advancements in the treatment of diseases related to neuropeptide receptors.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile